Ismigen tab. sublingual 7mg # 30

Tablets flat-cylindrical with a scored, light cream color with brown blotches and a faint smell of mint

Pharmaco-therapeutic group

N4 Acute and subacute upper and lower respiratory tract infections: bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis media, including complications after influenza (treatment as part of combination therapy).

Recurrent infections of the upper and lower respiratory tract, chronic bronchitis ¬ (prevention of exacerbations).

Application during pregnancy and during breastfeeding

Contraindicated

Dosage form

Sublingual tablets 7 mg.

10 tablets in a blister strip of polyvinyl chloride film and aluminum foil.

1 or 3 blisters together with instructions for use in a cardboard box.

Shelf life

3 years.

Do not use after the expiration date.

Category

Immunostimulating agent

Name ENG

ISMIGEN

Clinical and pharmacological group

Immunostimulating drug

ATX code

Other immunostimulants

Dosage

7mg

Structure

Lyophilized bacterial lysates - 50 mg, including the active component: lysates of bacteria Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae (types - TY1 ​​/ EQ11, TY2 / EQ22, TY3 / EQ14, TY5 / EQ15, TY5 / EY47 / EQ 24), Klebsiella pneumoniae, Klebsiella ozaenae, Haemophilus influenzae b, Neisseria catarrhalis - 7.0 mg excipient: glycine - 43 mg.

Excipients - microcrystalline cellulose 150.0 mg, calcium hydrogen phosphate dihydrate 35.0 mg, colloidal silicon dioxide 10.0 mg, magnesium stearate 3.0 mg, ammonium glycyrrhizinate 1.2 mg, mint flavor 0.8 mg.

Indications

Acute and subacute infections of the upper and lower respiratory tract: bronchitis tonsillitis pharyngitis laryngitis rhinitis sinusitis otitis media, including complications after influenza (treatment in combination therapy). Recurrent infections of the upper and lower respiratory tract, chronic bronchitis (prevention of exacerbations) ...

Contraindications

Hypersensitivity to the active and / or auxiliary components of the drug, autoimmune diseases, pregnancy, breastfeeding, children under 3 years of age.

Storage conditions and periods

Store at a temperature not exceeding 25 ° C.

Keep out of the reach of children.

INN / Active ingredient

Bacterial lysates

Specifications

Category

Antiviral

,

Antimicrobial agents

Scope of the medicinal product

The immune system

Release form

Tablet

Manufacturer country

Italy

Package quantity, pcs

thirty

Scope of application

Pulmonology

,

Immunology

Minimum age from

3 years old

Way of introduction

Under the tongue

Vacation conditions

Without recipe

Brand name

Stada

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Immunostimulating agent

Anatomical and therapeutic characteristics

L03AX Other immunostimulants

Dosage form

Sublingual tablets

Packaging

Cardboard box

The target audience

Adult

Expiration date in days

1095

Package weight, g

thirty

Mode of application

:

Under the tongue take on an empty stomach. The tablet should be kept under the tongue until it is completely dissolved. Sublingual tablets should not be sucked, chewed or swallowed. Acute and subacute infections of the upper and lower respiratory tract 1 tablet per day until the symptoms of the disease disappear (at least 10 days). Recurrent infections of the upper and lower respiratory tract, prevention of exacerbations of chronic respiratory diseases 1 tablet per day for 10 days. The preventive course includes three cycles of 10 days with 20-day intervals between them. The preventive course should be carried out no more than 1-2 times a year. If you skip taking the next dose, you should not double it the next time you take it. If after treatment there is no improvement or the symptoms worsen, or new symptoms appear, you should consult your doctor.Use the drug only according to the indications, the method of administration and the doses indicated in the instructions.

Dosage (volume) of the substance in the preparation

:

bacterial lysates, incl.

Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae (types - TY1 ​​/ EQ11, TY2 / EQ22, TY3 / EQ14, TY5 / EQ15, TY8 / EQ23, TY47 / EQ24), Klebsienseella pneumella catarrhalis 7 mg